Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in <scp>HBV</scp>‐infected individuals treated with pegylated interferon—implications for stopping rules and the <scp>HBV</scp> cure programme-Reference-Cited by-同舟云学术

Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV‐infected individuals treated with pegylated interferon—implications for stopping rules and the HBV cure programme

Published:2024-07-17 Issue:5 Volume:60 Page:650-651
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lok James¹^ORCID

Affiliation:

1. Institute of Liver Studies King's College Hospital London UK

Abstract

LINKED CONTENTThis article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.18131 and https://doi.org/10.1111/apt.18174

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.18142

Reference10 articles.

1. Global Hepatitis Report 2024: Action for Access in Low‐ and Middle‐Income Countries.2024.https://www.who.int/publications/i/item/9789240091672

2. Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients

3. Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels

4. Serum sPD‐1 and sPD‐L1 as predictive biomarkers for HBsAg clearance in HBeAg‐negative CHB patients undergoing IFN‐based therapy

5. PD-1 signaling in primary T cells

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply;Alimentary Pharmacology & Therapeutics;2024-07-17